United States
China
India
Japan
Singapore
South Africa
Sweden
United Kingdom
As a leading publisher of trusted science, technology, medicine, humanities and social sciences research, Taylor & Francis is committed to helping public health authorities, researchers, clinicians and the general public contain and manage the spread of COVID-19.
This microsite provides links and references to all relevant COVID-19 research articles, book chapters and information that can be freely accessed on Taylor & Francis Online and Taylor & Francis ebooks in support of the global efforts in diagnosis, treatment, prevention and further research into COVID-19. As signatories to NIH’s Access to Research initiative, along with the Wellcome Trust’s coordinated action on sharing research data and findings relevant to the outbreak, Taylor & Francis has been working with WHO to ensure this content is clearly signposted. We are also aligning the OSTP’s initiative to centralise resources on PubMed and are currently working with them to ensure rapid human and machine-readable access (where possible) to research articles and data through the NLM’s LitCovid portal.
More research in this field has been collated by colleagues at F1000Research, through a dedicated Gateway which showcases research published in this area, including preprints, to ensure immediate access to the latest research developments https://f1000research.com/gateways/disease_outbreaks/coronavirus
Prioritising rapid publication of COVID-19 materials
We are working with our editors to prioritise peer review of all relevant research. We are also focusing our workflow to ensure that materials related to the outbreak are fast-tracked through the publication process once they are approved. Editors are proactively encouraging authors to publish and share the data that forms the basis of their research in line with FAIR data principles, and our own data policies.
We are continually monitoring the developments of the coronavirus and spread of COVID-19, and we will continue to update the content on this site on a regular basis.
Journals
1-659 of 4,900+ results.
Access the full Coronavirus Research Archive
- research-articleDiagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR
- otherASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing
- research-articleHigh sensitivity troponin and COVID-19 outcomes
- research-articleCOVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention
- research-articleMontelukast in hospitalized patients diagnosed with COVID-19
- article-commentaryβ-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19
- research-articlePharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)
- research-articleCorticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital
- research-articleAn Evaluation of Serum 25-Hydroxy Vitamin D Levels in Patients with COVID-19 in New York City
- research-articleLow Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study
- research-articleSARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department
- research-articleIn silico prediction of SARS-CoV-2 main protease and polymerase inhibitors: 3D-Pharmacophore modelling
- research-articleMetabolomic profiling of three Araucaria species, and their possible potential role against COVID-19
- research-articleRepurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2
- research-articleAnti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment
- research-articleIn silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase
- research-articleStructural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex
- research-articleUse of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials
- research-articleElevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia
- research-articleAnalytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory
- research-articleArtificially expanded genetic information systems (AEGISs) as potent inhibitors of the RNA-dependent RNA polymerase of the SARS-CoV-2
Books
- research-articleThe relationship between positivity for COVID-19 RT-PCR and symptoms, clinical findings, and mortality in Turkey
- research-articlePDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia
- research-articlePredictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study
- research-articleImpact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases
- research-articleCorticosteroids treatment in severe patients with COVID-19: a propensity score matching study
- review-articleA systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations
- research-articleStructural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis
- research-articleTopological Study of Hydroxychloroquine Conjugated Molecular Structure Used for Novel Coronavirus (COVID-19) Treatment
- review-articleThe immune dysregulations in COVID-19: Implications for the management of rheumatic diseases
- research-articleRole of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19)
- research-articleClinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain
- research-articleMolecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19
- research-articleADOPT: automatic deep learning and optimization-based approach for detection of novel coronavirus COVID-19 disease using X-ray images
- research-articleIn silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase
- research-articleInsight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study
- research-articleThe assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease
- research-articleConvalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies
- research-articleAn in silico analysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease
- research-articleBiomarkers and short-term prognosis in COVID-19
- research-articleProspecting for Cressa cretica to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2
- research-articleEnfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study
- research-articleVitamin D Deficiency and Low Serum Calcium as Predictors of Poor Prognosis in Patients with Severe COVID-19
- research-articleIn silico study of the interactions of Pilocarpus microphyllus imidazolic alkaloids with the main protease (Mpro) of SARS-CoV-2
- research-articlePredictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections
- research-articleACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor
- research-articleSearching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets
- research-articleIdentification of potential SARS-CoV-2 Mpro inhibitors integrating molecular docking and water thermodynamics
- review-articleG6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)
- research-articleIn silico design of multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein
- research-articleVirtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV
- research-articleFisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study
- research-articleChanges of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease
- research-articleDeveloping multiplex ddPCR assays for SARS-CoV-2 detection based on probe mix and amplitude based multiplexing
- research-articleIn silico analysis of phytochemicals as potential inhibitors of proteases involved in SARS-CoV-2 infection
- research-articleRapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications
- research-articleSmall molecule stabilization of non-native protein-protein interactions of SARS-CoV-2 N protein as a mechanism of action against COVID-19
- research-articleDrug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges
- research-articleDual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin
- research-articlePrediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing
- research-articleDesign and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes
- research-articleSensitivity and specificity of 14 SARS-CoV-2 serological assays and their diagnostic potential in RT-PCR negative COVID-19 infections
- research-articleStructure and dynamics of membrane protein in SARS-CoV-2
- research-articleIncreased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients
- review-articleThe cardiovascular aspect of COVID-19
- research-articleMultitarget in silico studies of Ocimum menthiifolium, family Lamiaceae against SARS-CoV-2 supported by molecular dynamics simulation
- research-articleRisk factors of mortality and contribution of treatment in patients infected with COVID-19: a retrospective propensity score matched study
- research-articleAnisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation
- research-articleClinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.
- research-articleIn vitro antimicrobial, physicochemical, pharmacokinetics and molecular docking studies of benzoyl uridine esters against SARS-CoV-2 main protease
- review-articleEmerging role of artificial intelligence in therapeutics for COVID-19: a systematic review
- research-articleBiflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: a molecular docking and molecular dynamics approach
- research-articleOver time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure
- research-articleReduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?
- research-articleClinical characteristics of COVID-19 patients with asthma in Wuhan, China: a retrospective cohort study
- research-articleDesign of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach
- research-articleEvaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach
- research-articleClinical course of novel COVID-19 infection in pregnant women
- research-articleDandelion and focal crazy paving signs: the lung CT based predictors for evaluation of the severity of coronavirus disease
- research-articleConsiderations for the use and study of exogenous surfactant in respiratory disease from COVID-19
- research-articleHigh sensitivity Troponin-T for prediction of adverse events in patients with COVID-19
- research-articleA biomarker based severity progression indicator for COVID-19: the Kuwait prognosis indicator score
- research-articleRecombinant vaccines for COVID-19
- research-articleComputational gene expression profiling in the exploration of biomarkers, non-coding functional RNAs and drug perturbagens for COVID-19
- research-articleMolecular dynamics simulation perception study of the binding affinity performance for main protease of SARS-CoV-2
- research-articleAssociation of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients
- research-articleCordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19
- review-articleEndothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications
- research-articleCOVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study
- research-articleComputational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2
- research-articleThe risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtual case
- research-articleInhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach
- research-articleImmunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study
- research-articleHarnessing the non-specific immunogenic effects of available vaccines to combat COVID-19
- research-articleThe coronavirus disease 2019: the prevalence, prognosis, and recovery from olfactory dysfunction (OD)
- research-articleNanobodies: an unexplored opportunity to combat COVID-19
- research-articleMulti-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches
- research-articleIdentification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach
- research-articleRecent advances in vaccine and immunotherapy for COVID-19
- research-articleTraditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation
- research-articleSARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs
- editorialHighlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
- research-articleIdentification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods
- research-articleEmerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection: in silico approaches
- research-articleTargeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations
- research-articleComputer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves
- research-articleAn in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin α
- research-articleGlobal scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic
- research-articleUncaria tomentosa (cat’s claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling
- research-articleBinding mechanism and structural insights into the identified protein target of COVID-19 and importin-α with in-vitro effective drug ivermectin
- research-articleSecondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins
- editorialCan secondary lymphoid organs exert a favorable effect on the mild course of COVID-19 in children?
- research-articleExploring RdRp–remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV
- research-articleHigh-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
- research-articleNatural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach
- research-articleCaffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2
- research-articleA multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease
- research-articlePotential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study
- research-articlePrevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2
- research-articleDeep mutagenesis in the study of COVID-19: a technical overview for the proteomics community
- research-articleAntiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection
- research-articleStructural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds
- research-articleThe role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization
- research-articleDoes Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study
- research-articleComparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia
- research-articleMolecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19
- research-articleFinding potent inhibitors for COVID-19 main protease (Mpro): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA
- research-articleMolecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding
- research-articleIn silico exploration of small-molecule α-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2
- research-articleOptimization of hydroxychloroquine dosing scheme based on COVID-19 patients’ characteristics: a review of the literature and simulations
- research-articleBCG vaccine: a hope to control COVID-19 pandemic amid crisis
- research-articleMortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
- research-articleIdentification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms
- research-articleSecondary structure of the SARS-CoV-2 5’-UTR
- research-articleRepurposing drugs for treatment of SARS-CoV-2 infection: computational design insights into mechanisms of action
- research-articleCOVID-19: benefits and risks of passive immunotherapeutics
- research-articleIn silico modeling for quick prediction of inhibitory activity against 3CLpro enzyme in SARS CoV diseases
- research-articleRemdesivir, a remedy or a ripple in severe COVID-19?
- research-articleA computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
- research-articleCombined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves
- research-articleClinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study
- research-articleMolecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia
- research-articleTargeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach
- research-articleProspects for mucosal vaccine: shutting the door on SARS-CoV-2
- research-articleNaltrexone a potential therapeutic candidate for COVID-19
- research-articleIn-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15 proteins of SARS-CoV-2
- research-articleMolecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease
- research-articlePotential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses
- research-articlePharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases
- research-articleRepurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro
- research-articleInsights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding
- research-articleStructure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2
- research-articleAntitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis
- research-articleEmbedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience
- research-articleAn in-silico evaluation of dietary components for structural inhibition of SARS-Cov-2 main protease
- research-articleUtility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19)
- research-articleHydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection
- research-articleSwinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19
- research-articleIn silico designing of multi-epitope vaccine construct against human coronavirus infections
- research-articleIn silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins
- research-articlePredictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease
- review-articleAcute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19
- research-articleConformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors
- research-articleDeciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods
- research-articleIdentification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2
- research-articleIdentification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study
- research-articleAntiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19
- research-articleVirtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2
- research-articleIdentification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis
- research-articleMolecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2
- research-articleComputational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
- research-articleTargeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development
- research-articleComparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study
- research-articleDual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads
- research-articleCyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis
- research-articleVirtual screening, molecular dynamics and structure–activity relationship studies to identify potent approved drugs for Covid-19 treatment
- research-articleIn-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors
- research-articleTargeting virus–host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19
- research-articleApproach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study
- research-articleDrug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)
- research-articleThe latitude hypothesis, vitamin D, and SARS-Co-V2
- research-articleLoss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends
- research-articleComputational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease
- research-articleIdentification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1)
- research-articleOn the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity
- research-articleNetwork pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
- research-articleIdentification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor
- research-articlePotential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis
- research-articleNatural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery
- research-articleSuccessful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature
- research-articleScreening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study
- research-articleIn silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme
- editorialThe status surrounding chloroquine and other drugs as potential anti-infective agents for COVID-19
- research-articleRepurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
- research-articleImmunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine
- research-articleIn-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19
- research-articleScreening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets
- research-articleVirtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2
- research-articleSars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach
- research-articleIn silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2
- research-articlePromising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation
- research-articleRemdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach
- review-articleAdvances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
- research-articleNatural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation
- research-articleLeucoefdin a potential inhibitor against SARS CoV-2 Mpro
- research-articleWithanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
- research-articleAn in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease
- review-articleRepurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies
- research-articleLopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection
- research-articleDoes lopinavir measure up in the treatment of COVID-19?
- research-articleA computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem)
- research-articleIdentification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies
- research-articleAntiviral effects of probiotic metabolites on COVID-19
- reviewEffectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
- research-articleStructural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor
- research-articleIdentification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
- research-articleRepurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening
- research-articleFragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease
- research-articleMarine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study
- review-articleThe expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets
- research-articleWithanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity
- research-articleOld and re-purposed drugs for the treatment of COVID-19
- research-articleTopological Indices of Some Chemical Structures Applied for the Treatment of COVID-19 Patients
- research-articleTruncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent
- review-articleRemdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary
- research-articleIdentification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors
- research-articleIdentification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach
- review-articleDevelopment of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase
- research-articleIn-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
- research-articleMultifunctional nano-magnetic particles assisted viral RNA-extraction protocol for potential detection of COVID-19
- research-articleUsing integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
- research-articleFDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
- research-articleAn investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
- research-articleIdentification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
- research-articleClinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors
- research-articleFatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c)
- research-articleAn in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
- research-articleA molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2
- research-articlePractical Considerations When Performing Neurodiagnostic Studies on Patients with COVID-19 and Other Highly Virulent Diseases
- research-articlePeptide-like and small-molecule inhibitors against Covid-19
- research-articleMoroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
- research-articleRisk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study
- research-articlePrediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
- research-articleAndrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
- research-articleDiscovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
- research-articleUnderstanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures
- research-articleQuadruple therapy for asymptomatic COVID-19 infection patients
- research-articleReverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
- review-articleNovel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
- research-articleThe role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
- research-articlePre-incident Training to Build Resilience in First Responders: Recommendations on What to and What Not to Do
- research-articleDrug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
- review-articleA review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
- research-articleAssociation between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study
- research-articleIn-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
- article-commentaryClinical observation and management of COVID-19 patients
- article-commentaryClinical observation and management of COVID-19 patients
- rapid-communicationEmerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments
- rapid-communicationEmerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments
- research-articleRNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak
- research-articleGenomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- article-commentaryAntibodies to watch in 2020
- research-articleRecombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
- case-reportFeline infectious peritonitis: answers to frequently asked questions concerning FIP and coronavirus
- case-reportFeline infectious peritonitis: answers to frequently asked questions concerning FIP and coronavirus
- research-articleEmerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development
- research-articleCharacterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China
- research-articleA sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus
- research-articleComparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea
- research-articleA novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
- Original ResearchStructural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
- research-articleGenomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats
- reviewCritical evaluation of FDA-approved respiratory multiplex assays for public health surveillance
- research-articleVaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
- research-articleVaccines for epidemic infections and the role of CEPI
- research-articlePanblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
- article-commentaryRecent advancements in combination subunit vaccine development
- article-commentaryUnderstanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks — Implications for coronavirus vaccine development
- research-articleA novel variant of the infectious bronchitis virus resulting from recombination events in Italy and Spain
- research-articleA novel variant of the infectious bronchitis virus resulting from recombination events in Italy and Spain
- research-articleA metagenomic comparison of endemic viruses from broiler chickens with runting-stunting syndrome and from normal birds
- research-articleA metagenomic comparison of endemic viruses from broiler chickens with runting-stunting syndrome and from normal birds
- reviewBiosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
- otherDynamics of avian coronavirus circulation in commercial and non-commercial birds in Asia – a review
- otherDynamics of avian coronavirus circulation in commercial and non-commercial birds in Asia – a review
- editorialClinical implications of and lessons learnt from external assessment of Mers-CoV diagnostics
- editorialMiddle East respiratory syndrome: current status and future prospects for vaccine development
- review-articleCommunity-acquired pneumonia: An overview
- research-articleOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
- research-articleOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
- research-articleAnalysis of the complete genomic sequences of two virus subpopulations of the Australian infectious bronchitis virus vaccine VicS
- research-articleAnalysis of the complete genomic sequences of two virus subpopulations of the Australian infectious bronchitis virus vaccine VicS
- Original ResearchDesign of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach
- research-articleAirborne Microorganisms From Livestock Production Systems and Their Relation to Dust
- research-articleAirborne Microorganisms From Livestock Production Systems and Their Relation to Dust
- editorialDevelopment of a SARS vaccine: an industrial perspective on the global race against a global disease
- research-articleSARS vaccines: where are we?
- review-articleMolecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics
- research-articleMultiplex PCR theranostics of severe respiratory infections
- review-articleMolecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics
- research-articleRole of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease
- research-articleRoadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
- research-articleSARS vaccines: where are we?
- research-articleThe FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens
- research-articleDownstream processing of cell culture-derived virus particles
- research-articleDeveloping vaccines to counter bioterrorist threats
- research-articleExpecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses
- research-articleMiniaturized detection technology in molecular diagnostics
- research-articleProtein microarrays: high-throughput tools for proteomics
- research-articleExpecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses
- research-articleAdvantages of mRNA display selections over other selection techniques for investigation of protein–protein interactions
- review-articleTargeting CCL5 in inflammation
- research-articleAn experimental study of the survival of turkey coronavirus at room temperature and +4°C
- research-articleAn experimental study of the survival of turkey coronavirus at room temperature and +4°C
- research-articleThe diversity of viruses infecting humans
- research-articleThe diversity of viruses infecting humans
- research-articleInfectious bronchitis virus variants: a review of the history, current situation and control measures
- research-articleInfectious bronchitis virus variants: a review of the history, current situation and control measures
- review-articleCoronaviruses
- review-articleCoronaviruses
- research-articleEfficacy and safety of an attenuated live QX-like infectious bronchitis virus strain as a vaccine for chickens
- research-articleEfficacy and safety of an attenuated live QX-like infectious bronchitis virus strain as a vaccine for chickens
- research-articleA new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and non-vaccinated flocks in China
- research-articleA new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and non-vaccinated flocks in China
- review-articleDevelopment and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review
- review-articleDevelopment and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review
- research-articleMolecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain
- research-articleMolecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain
- research-articleInteraction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes
- research-articleInteraction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes
- research-articleThe isolation and Characterisation of six avian infectious bronchitis viruses isolated in morocco
- research-articleThe isolation and Characterisation of six avian infectious bronchitis viruses isolated in morocco
- research-articleAntigenic and immunogenic characterization of infectious bronchitis virus strains isolated in China between 1986 and 1995
- research-articleAntigenic and immunogenic characterization of infectious bronchitis virus strains isolated in China between 1986 and 1995
- research-articleLithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture
- research-articleLithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture
- research-articlePotential therapies for coronaviruses
- research-articleAntiviral applications of RNAi for coronavirus
- review-articleThe role of reverse genetics in the development of vaccines against respiratory viruses
- review-articleThe role of reverse genetics in the development of vaccines against respiratory viruses
